Last reviewed · How we verify
NCT05351125: CHD
Outcomes Of Interventional Catheterization In Infants Less Than 3 Months With Critical Congenital Heart Disease
trial testing cardiac catheterization in Critical Congenital Heart Disease in 40 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | YHAlattar |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 28 June 2022 |
| Primary completion | 30 December 2023 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- cardiac catheterization
Conditions studied
- Critical Congenital Heart Disease — all drugs for Critical Congenital Heart Disease →
Sponsor
YHAlattar
Who can join
Adults 12 Hours to 3 Months, any sex, with Critical Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Congenital heart disease is the most common birth defect affecting mostly 1 in 100 births(1), critical congenital heart disease is when there is low systemic cardiac output which requires urgent surgery or catheter intervention in the first year of life(2), in low-income countries CCHD is associated with severe high mortality rate due to low health resources, in high-income countries, CCHD is associated with life-long morbidities and a high burden on the health care systems(1-3)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05351125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cardiac catheterization
Trials testing the same drug.
- NCT06031077 — Effectiveness and Safety of Distal Left Transradial Access in Coronary Procedures. · completed
- NCT03564522 — Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of The · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05351125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by YHAlattar
- Last refreshed: 28 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05351125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing